Inversa Prime SOCIMI, S.A. (BME:YIPS)

Orchard Therapeutics Revenue

In the year 2024, Inversa Prime SOCIMI had annual revenue of 3.37M EUR with 9.43% growth. Inversa Prime SOCIMI had revenue of 1.80M in the half year ending December 31, 2024, with 47.25% growth.

• Revenue: 3.37M
• Revenue Growth: +9.43%
• P/S Ratio: 23.33
• Revenue / Employee: 3.37M
• Employees: 1
• Market Cap: 78.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.37M	290.64K	9.43%
Dec 31, 2023	3.08M	882.50K	40.14%
Dec 31, 2022	2.20M	974.53K	79.63%
Dec 31, 2021	1.22M	689.20K	128.91%
Dec 31, 2020	534.64K	143.93K	36.84%